Advertisement

Q&A

Expert Q&A
Dr Tang
Expert Q&A
02/20/2024
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
02/20/2024
Expert Q&A
Expert Q&A
02/14/2024

Lisa Jones, MA, RDN, LND, FAND; Rachel Stahl Salzman, MS, RDN, CDN, CDCES

Lisa Jones, MA, RDN, LND, FAND; Rachel Stahl Salzman, MS, RDN, CDN, CDCES
Diabetes technology has improved significantly in recent years, including the use of blood glucose meters, continuous glucose monitors (CGM), cutting-edge insulin pumps, and more. Lisa Jones, MA, RDN, LND,...
02/14/2024
Expert Q&A
W. Clay Jackson, MD, DipTH
Expert Q&A
02/05/2024
In this Q&A, W. Clay Jackson, MD, DipTH, speaks about various aspects of schizophrenia, including the symptoms, risk factors, and associated controversies surrounding these risk factors.
02/05/2024
expert Q&A
expert Q&A
01/31/2024
In this Q&A, Supriya Mishra, MD, discusses the relationship between psoriatic arthritis and periodontitis, including how these conditions may adversely impact patients’ quality of life.
01/31/2024
Expert Q&A
benjamin cohen md
Expert Q&A
01/24/2024
Despite several medical therapies currently available to treat Crohn disease, many patients still undergo surgical treatment. Benjamin Cohen, MD, co-section head and clinical director of the Department of...
01/24/2024
Expert Q&A
Adam Faye
Expert Q&A
01/16/2024
In this Q&A, Adam Faye, MD, MS, discusses the implications of his team’s study examining the relationship between antibiotic use and onset of ulcerative colitis and Crohn disease in adults aged 60 years...
01/16/2024
expert Q&A
expert Q&A
12/31/2023

Emile d’Angremont, MSc

Emile d’Angremont, MSc
In this interview, Emile d’Angremont, MSc, discusses the results of a recent study examining the use of cholinesterase inhibitors for the management of psychotic symptoms among patients with...
12/31/2023
expert Q&A
expert Q&A
12/11/2023

Cécile Philippoteaux, MD, MSc, PharmD

Cécile Philippoteaux, MD, MSc, PharmD
In this expert Q&A, Cécile Philippoteaux, MD, MSc, PharmD, discusses the results of her team’s recent review, including the prevalence, characteristics, definition, and the next steps for research in...
12/11/2023
Expert Q&A
Expert Q&A
12/09/2023
Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.
12/09/2023
expert Q&A
expert Q&A
12/06/2023
In this Q and A, Valentina Celoria, MD, discusses the relationship between the human microbiome and psoriatic disease, as well as what this relationship may mean for future treatments.
12/06/2023